Validity of Bispectral Index Monitoring During Deep Sedation
Validity of Bispectral Index Monitoring During Deep Sedation for Botulinum Toxin Injection in Children With Cerebral Palsy
Sponsor: Yeungnam University College of Medicine
Listed as NCT02096549, this observational or N/A phase trial focuses on Cerebral Palsy and remains completed. Sponsored by Yeungnam University College of Medicine, it has been updated 10 times since 2014, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Feb 2024 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Feb 2024 [monthly]
Completed
▶ Show 5 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jul 2017 — Apr 2018 [monthly]
Completed NA
Status: Recruiting → Completed
-
May 2017 — Jul 2017 [monthly]
Recruiting NA
Status: Suspended → Recruiting
-
Jan 2017 — May 2017 [monthly]
Suspended NA
First recorded
Mar 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Yeungnam University College of Medicine
For direct contact, visit the study record on ClinicalTrials.gov .